Bellerophon Therapeutics
BLPH
$0.05130
Share price
-6.90%
Change (1 day)
-99.34%
Change (1 year)
Categories
Bellerophon Therapeutics (BLPH) - Cash on Hand
Cash on Hand as of September 2023 : $4.38 M
According to Bellerophon Therapeutics
's latest financial reports the company has $4.38 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Bellerophon Therapeutics - Cash on Hand chart (from 2013 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $6.92 M | -72.01% |
| 2021-12-31 | $24.73 M | -47.99% |
| 2020-12-31 | $47.55 M | 381.64% |
| 2019-12-31 | $9.87 M | -40.68% |
| 2018-12-31 | $16.64 M | -47.69% |
| 2017-12-31 | $31.81 M | 60.92% |
| 2016-12-31 | $19.77 M | -17.84% |
| 2015-12-31 | $24.06 M | 43.13% |
| 2014-12-31 | $16.81 M | |
| 2013-12-31 | $N/A | |
| 2012-12-31 | $N/A |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Abbott Laboratories ABT | $7.27 B | 166,011.36% | 🇺🇸 USA |
 Baxter BAX | $3.19 B | 72,789.09% | 🇺🇸 USA |
 Lantheus Holdings LNTH | $0.71 B | 16,186.08% | 🇺🇸 USA |
 Abeona Therapeutics
ABEO | $52.22 M | 1,091.83% | 🇺🇸 USA |